Clinical trials
Emphysema trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 6 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Recruiting | 7 |
| Terminated | 5 |
| Withdrawn | 4 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 5 |
| Beth Israel Deaconess Medical Center | 3 |
| VA Office of Research and Development | 3 |
| Boston Scientific Corporation | 2 |
| National Jewish Health | 2 |
| Olympus Corporation of the Americas | 2 |
| Pulmonx Corporation | 2 |
| The Cleveland Clinic | 2 |
| University of North Carolina, Chapel Hill | 2 |
| Apreo Health, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emphysema | 38 |
| Pulmonary Disease, Chronic Obstructive | 34 |
| Bronchitis, Chronic | 10 |
| Lung Diseases | 4 |
| Pulmonary Fibrosis | 4 |
| Bronchiectasis | 3 |
| Cystic Fibrosis | 2 |
| Dyspnea | 2 |
| Hypertension, Pulmonary | 2 |
| Lung Diseases, Interstitial | 2 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.